tiprankstipranks
Leadership Shift at Achilles Therapeutics
Company Announcements

Leadership Shift at Achilles Therapeutics

Achilles Therapeutics (ACHL) has released an update.

Don't Miss our Black Friday Offers:

Achilles Therapeutics has announced changes in its leadership, with Karl Peggs stepping down as Chief Medical Officer to dedicate more time to his roles at UCLH and NIHR UCLH BRC, but he will continue to advise the company. Matilde Saggese, previously Vice President and Medical Director, has been appointed as the Interim CMO.

For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAchilles Therapeutics receives approval to transfer to Nasdaq Capital Market
TipRanks Auto-Generated NewsdeskAchilles Therapeutics Explores Strategic Options Amid Financial Update
TheFlyAchilles Therapeutics reports Q3 EPS (48c) vs. (42c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App